| Sudarshan Pharma Industries Ltd |
|
Registered Office:
301 3rd Floor Aura Biplex,SV Road Borivali(West)
,
Mumbai
-
400092
,
Maharashtra
, India.
Phone :
91-22-42221111 Fax:
Email : compliance.spil@gmail.com
Website : www.sudarshanpharma.com
|
Public issue of 68,62,400 equity shares of face value of  10.00 each ("Equity Shares") of Sudarshan Pharma Industries Limited (the "Company" or the "Issuer") for cash at a price of 73.00 per equity share including a share premium of 63.00 per equity share (the "Issue Price") aggregating to 50.10 crores ("The Issue") of which 3,44,000 equity shares aggregating to 2.51 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 65,18,400 equity shares aggregating to 47.59 crores (the "Net Issue"). The issue and the net issue will constitute 28.52% and 27.09% respectively of the post issue paid-up equity share capital of the company.
Issue Price : 73 per equity share of face value of 10 each.
Anchor Investor Issue Price : 73 per equity shares
The issue price is 7.3 times of the face value.
Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 09-Mar-23 |
14-Mar-23 |
Rs73.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :1600 Further Multiples of :1600 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
42.20 |
| Gretex Corporate Services Ltd |
|
| Project Financed through Current Offer |
50.10 |
|
| Post Issue Equity Share Capital |
24.07 |
|
| Issue Price |
Rs73.00 |
|
|